Creatine in menopause: what the evidence actually shows
Creatine is one of the most studied supplements in sports science and has become heavily marketed to menopausal women, which makes separating evidence from enthusiasm worthwhile. The reasonable evidence is for strength and lean mass gains when combined with resistance training; creatine without training does little. Evidence in postmenopausal women specifically is encouraging but limited, and claims about bone density, mood and cognition are considerably less settled than the marketing suggests.
What it does
Creatine is a compound the body makes and also obtains from meat and fish. It is stored in muscle as phosphocreatine and serves as a rapid energy buffer for short, intense effort.
Supplementation raises muscle stores, which allows slightly more work per training session. Over time that additional training stimulus produces measurable strength and lean mass gains.
The mechanism is therefore indirect: creatine does not build muscle. It permits more of the training that does. This is the single most important thing to understand before deciding whether it is relevant to you.
Why it is being marketed to this group
Women generally have lower baseline muscle creatine stores than men, and dietary intake tends to be lower. There is a plausible argument that the potential to benefit is therefore greater.
Set against the well-documented acceleration of muscle loss across the menopause transition, the rationale is coherent. Coherent rationale is not the same as demonstrated benefit, and the two get conflated constantly in this area.
Where the evidence is reasonable, and where it is not
Reasonable: creatine combined with resistance training improves strength and lean mass in postmenopausal women in several trials. This is the best-supported claim and it always includes the training.
Less settled: effects on bone density. Some studies of creatine with resistance training have shown favourable changes in bone geometry or density, others have not, and study durations are generally short relative to how slowly bone changes.
Thin: claims about mood, cognition, brain fog and sleep. There is early work and a plausible mechanism, but the confident claims circulating on social media run well ahead of the data.
Common misconceptions
- It is not a hormone, and it does not act on estrogen or any hormonal pathway
- It is not an anabolic steroid, despite the association the word carries
- It does not cause kidney damage in people with healthy kidneys, which has been examined repeatedly; it remains a reason for caution in existing kidney disease
- Weight gain in the first weeks is water drawn into muscle, not fat
- It does very little without resistance training, which is the part the marketing tends to omit
When to see someone
Check with a clinician before starting if you have kidney disease, take medication affecting kidney function, or are pregnant or breastfeeding.
Supplements are variably regulated depending on where you live, so third-party testing is worth looking for. This page does not recommend a dose or a product, and a specific regimen is a conversation with a clinician or dietitian rather than something to take from an article.
Wondering if this is perimenopause?
Two free next steps: check where your symptoms and cycle sit against the clinical criteria, or go straight to clinicians who treat this every day.
Sources
- The Menopause Society — patient education
- National Institute on Aging — Dietary supplements
- NIH Office of Dietary Supplements
This page is general information, not medical advice, and it does not recommend or rule out any treatment for you personally. If something here contradicts what your clinician tells you, your clinician knows your situation — this page does not.